Tolterodine should be referred to as Tolterodine Tartrate, which belongs to the muscarinic receptor antagonists in the clinic to treat overactive bladder syndrome with side effects such as dry mouth, constipation, allergy and diarrhea. Tolterodine tartrate belongs to the Western medications, which are used clinically to treat symptoms such as urinary urgency, frequency, and urge incontinence caused by overactive bladder syndrome. The current side effects of the drug mainly include systemic reactions such as allergic-like reactions and angioedema; cardiovascular reactions such as tachycardia and palpitations (rapid heartbeat, often accompanied by panic); gastrointestinal reactions such as diarrhea, as well as central and peripheral nervous system reactions such as confusion, disorientation, memory impairment and hallucinations. In addition, the drug should not be used in diseases such as urinary retention, gastric retention, uncontrolled narrow-angle glaucoma. It should be used with caution in patients with myasthenia gravis, severe ulcerative colitis, and toxic megacolonitis. A doctor should be consulted for specific medication.